Pharmacy Technician Pulse

Putting patients at the centre of innovation starts with clinical trial access

pharmaphorum

NOVEMBER 28, 2023

Putting patients at the centre of innovation starts with clinical trial access Mike.Hammerton Tue, 28/11/2023 - 14:00 Bookmark this

Clinical research in 2021: A new era of collaboration and innovation

pharmaphorum

JANUARY 25, 2021

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. clinical trial diversity. public education.

Communication

Communication Patient Care FDA

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part ii)

pharmaphorum

NOVEMBER 10, 2022

To continue with pharmaphorum’s coverage of Day One of The Economist’s 8th Annual World Cancer Series congress in Brussels, Belgium this week – where the foci were “innovation, equity, and excellence” – after the opening addresses came a panel on the priorities for innovation and excellence in cancer care within Europe.

Vaccines

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling

And then there were three: another FDA adcomm member quits over Aduhelm

pharmaphorum

JUNE 11, 2021

He also said that the FDA’s approval was based on the “debatable premise that the drug’s effect on brain amyloid was likely to help patients with Alzheimer’s,” which was not given enough time for discussion at the adcomm meeting.

FDA

FDA Medical Schools

How one pharma “family business” places patients first

pharmaphorum

OCTOBER 26, 2022

And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.

Patient Care

Patient Care FDA

Healthcare that no longer leaves out the patient

pharmaphorum

DECEMBER 1, 2020

This structure relies on in-person visits of patients to operate and become profitable. But when the industry suddenly shifted due to COVID-19, so too did the power dynamics of the patient-provider relationship. Burden on the patient. Omri Shor, CEO of Medisafe, explores how. Tech shift.

Vaccines

Vaccines Insurance Patient Care

Transformational therapies demand a new mindset

pharmaphorum

MARCH 30, 2021

Chris Gray leads Innovation and Ventures for Adelphi’s Healthcare Communications agencies, whose long-running Renaissance series has been discussing the implications of ‘ transformational value ’. As more of these therapies emerge, there are lessons from the front-runners about the need for new approaches starting with clinical trials.

Communication

Communication Labelling

France’s biotech ecosystem is primed for growth – it’s time to feed it

pharmaphorum

SEPTEMBER 13, 2021

After some years of stagnant funding and growth France is now at an inflection point for health care innovation, says Jeito Capital’s Dr Rafaèle Tordjman. To sustain that momentum, France has doubled down on its commitment to fostering innovation here, with the ambition of becoming a leader in Europe by 2030.

Healthtech: detecting early risks of diseases and optimising treatments

Pharmaceutical Technology

NOVEMBER 4, 2022

And as health services start to recover from the global pandemic, healthtech can also result in substantial financial savings. At the core of health innovation in Scotland is the collaboration between industry, academia, and government. All data is anonymised to protect patient confidentiality.

Chemotherapy

Chemotherapy Documentation

Making ATMPs a reality for rare disease patients

European Pharmaceutical Review

FEBRUARY 28, 2024

The implementation of the EU’s Health Technology Assessment Regulation (HTAR) 1 will play a key role in shaping the patient access pathway for ATMPs such as cell and gene therapies. This group now has the challenge of developing methodologies to assess the relative clinical effectiveness of a new therapy.

Alexion’s Camilla Harder Hartvig on making the impossible possible in rare disease

pharmaphorum

MARCH 30, 2021

Alexion’s senior vice president of its international business talks to Paul Tunnah about the importance of “people-centred and vulnerable” leadership, the surprising impacts of COVID and the promising future for treating patients with rare diseases. . Once you start working in rare disease, you get so inspired by the patients.

Hospitals

Hospitals Communication Pharmaceutical Companies Pharmaceutical Companies

Latin America: How pharma can navigate a complex market

pharmaphorum

DECEMBER 7, 2020

His company, UK-based Masters Speciality Pharma , partners with big pharma, SME and biotech companies to bring their products to patients in developing markets. Although Latin America is a vast and varied region, it is one that, generally, presents difficulties for the industry as access to treatments is limited.

FDA

FDA Pharmaceutical Companies Pharmaceutical Companies Hospitals

How digital pathways are changing healthcare

pharmaphorum

JULY 9, 2021

Digital technologies are proving their value by allowing for better care, improved adherence and a more connected ecosystem between doctors, patients and pharma. In an ideal world, we’d like every patient to have their own pain specialist, psychologist, dietitian, etc.,

Hospitals

Hospitals Communication Immunization Pharmaceutical Companies

A glance back to Pharma Integrates, London 2022 – part iii

pharmaphorum

JANUARY 23, 2023

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. It starts with this week, the global population passing eight billion. AI drug discovery? Mountain one.

Finding a cure: How cell and gene therapies could revolutionise medicine

Pharmaceutical Technology

JANUARY 26, 2023

Patients with conditions with limited treatment options could one day be cured by these breakthrough therapeutics, with treatments for everything from cancers, Parkinson’s and Alzheimer’s to strokes, spinal cord injuries and diabetes. In turn, this has the potential to enable more people to receive essential treatments.

Communication

Pharmacy Technician Pulse

Putting patients at the centre of innovation starts with clinical trial access

Clinical research in 2021: A new era of collaboration and innovation

Trending Sources

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part ii)

And then there were three: another FDA adcomm member quits over Aduhelm

How one pharma “family business” places patients first

Healthcare that no longer leaves out the patient

Transformational therapies demand a new mindset

France’s biotech ecosystem is primed for growth – it’s time to feed it

Healthtech: detecting early risks of diseases and optimising treatments

Making ATMPs a reality for rare disease patients

Alexion’s Camilla Harder Hartvig on making the impossible possible in rare disease

Latin America: How pharma can navigate a complex market

How digital pathways are changing healthcare

A glance back to Pharma Integrates, London 2022 – part iii

Finding a cure: How cell and gene therapies could revolutionise medicine

Stay Connected